ArticleFrontiers in public health2025
Doxycycline prophylaxis for sexually transmitted infections prevention among men who have sex with men in China.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Men who have sex with men (MSM) have a high prevalence of sexually transmitted infections (STIs). The efficacy of doxycycline prophylaxis in STIs prevention has been demonstrated. This study aimed to examine the utilization of doxycycline prophylaxis among MSM in China, providing evidence to inform future policies and guidelines. Methods: Between June and July 2025, a cross-sectional survey was conducted in China, using a convenience sampling method to recruit eligible MSM. Sociodemographic characteristics, behavioral information, and doxycycline prophylaxis utilization experience were collected from the participants. Logistic regression analysis was performed to identify factors associated with doxycycline prophylaxis utilization among MSM. Results: A total of 508 MSM were recruited, with a median age of 31.5 (28.0-64.0) years. The utilization proportion of doxycycline prophylaxis was 13.4% (68/508). Multivariate logistic regression analysis indicated that age >35 years (aOR = 0.393, 95%CI: 0.172-0.898), engagement in casual sex (aOR = 2.187, 95%CI: 1.045-4.578), engagement in commercial sex (aOR = 3.986, 95%CI: 1.622-9.794) and HIV PrEP/PEP experience (aOR = 20.220, 95%CI: 9.061-45.123) were significantly associated with doxycycline prophylaxis use. Conclusions: As an effective strategy for STIs prevention, doxycycline prophylaxis use among MSM in China remains at a relatively low level. Age and sexual behaviors are associated with its use. Future efforts should focus on strengthening STIs-related education, enhancing MSM's risks awareness, and promoting the appropriate use of doxycycline prophylaxis for STIs prevention within this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.